Abstract
INTRODUCTION
Small-sized lung cancers tend to be found during screenings performed using computed tomography (CT). Apart from small tumours, CT can also detect tumours that are faint on chest roentgenograms, such as those with ground glass opacity (GGO) [1] . GGO on thin-section CT is one of the most favourable prognostic factors in lung cancer. Most previous reports have evaluated the size of the GGO in one dimension in which the authors have claimed that the ratio of GGO to consolidation was important for predicting the prognosis [2] [3] [4] [5] [6] [7] [8] .
Radiologically, these tumours are often classified into three categories: pure ground glass nodule (GGN) having only a GGO component; part-solid tumour (PST) having both GGO and consolidation components and solid tumour (ST) having only a consolidation component based on thin-section CT. Meanwhile, some oncologists may call it a mixed GGN or nonsolid tumour rather than a PST [9, 10] . Furthermore, the term 'PST' or 'mixed GGN' is frequently misused at conferences because one of the tumours had a very small pulmonary consolidation close to a pure GGN, whereas the other had a large consolidation. This misuse occurs despite the fact that many researchers have reported that the ratio of GGO to consolidation is important for predicting prognosis [7, 11] . There is no consensus on the use of this terminology, which can cause problems in clinical practice.
We often use the consolidation-to-tumour (C/T) ratio to measure the size of the GGOs. The maximum diameter of the consolidation is divided by the maximum diameter of the tumour to obtain the C/T ratio. Previous articles have concluded that lung adenocarcinomas with a C/T ratio of 0.5 or less could be noninvasive [11, 12] . Thus, some surgical oncologists have divided PSTs into two groups on the basis of the C/T ratio of 0.5 [13, 14] . However, we thought this caused a significant problem because the 5-year survival rates of patients with pure GGNs is very good, being almost 100%. Most of these tumours are adenocarcinomas in situ, whereas STs may have an occult pN1 or N2, which probably worsens the prognosis [2, 4, 15] . Therefore, there is no consensus regarding the division of PST into two categories on the basis of a C/T ratio of 0.5 ( Fig. 1) .
Thus, our objective was to determine whether it is appropriate to classify PST into two groups on the basis of a C/T ratio of 0.5 and to propose a simple resolution for this debate.
MATERIALS AND METHODS

Study population
A retrospective study was conducted on 775 consecutive patients with resected lung adenocarcinoma of clinical stage IA between February 2008 and March 2013. All patients underwent preoperative thin-section CT, and the authors reviewed the radiological findings for all the cohorts. Thin-section CT was performed to evaluate the entire lung with a collimation of 1-2 mm. The lung was photographed with a window level of -500 to -700 Hounsfield units (HU) and a window width of 1500-2000 HU as the lung window. GGO was defined as a misty increase in lung attenuation without obstructing the underlying vascular markings. In addition, on the basis of thin-section CT scans, we defined pure GGN as having only a GGO component, PST as having both GGO and consolidation components, and ST as having only a consolidation component. Furthermore, we used the C/T ratio to measure the size of the GGOs. The maximum diameter of the consolidation was divided by the maximum tumour diameter to give the C/T ratio. The maximum diameters of the consolidation and of the tumour were obtained from the same layer on thin-section CT scans in many cases; in other cases, they were obtained from the separate layer if needed. Strategies for treating tumours with the GGO component, especially pure GGN, are controversial. In our institute, PSTs were resected, and we tried to resect tumours consisting solely of a GGO component larger than 10 mm. However, some tumours that could not be resected due to clinical factors such as age, cardiac dysfunction or pulmonary dysfunction were monitored closely. Tumours that consisted solely of a GGO component smaller than 10 mm were not resected but monitored closely.
Study design
We divided PST into two categories, using the radiological criterion of a C/T ratio of 0.5. Lung cancers were classified into four groups: (i) pure GGN (pGGN) (C/T ratio = 0); (ii) ground glasspredominant PST (GP-PST) (0 < C/T ratio < 0.5); (iv) consolidationpredominant PST (CP-PST) (0.5 < _ C/T ratio < 1) and (D) ST (C/T ratio = 1). We investigated the clinicopathological features and prognoses of GP-PST and CP-PST. In this study, prognosis was assessed by recurrence-free survival because PSTs were early-stage lung cancer and they sometimes had an epidermal growth factor receptor gene (EGFR) mutation that impacted overall survival. The patients were followed up every 3 or 6 months after the operation for at least 5 years and underwent CT scans of the chest and upper abdomen every 6 months or 1 year and CT or MRI scans of the brain, bone scintigraphy or PET-CT scans every year for the first 2 years if needed. Thereafter, they received these scans at least once a year. The day of recurrence was determined by a professor or associate professor of thoracic oncology.
We estimated the grade of malignancy using lymphatic invasion rather than nodal involvement. Because the incidence of nodal involvement was too low in PST and we did not perform systematic mediastinal lymph node dissection in all cases, lymphatic invasion by the tumour was considered appropriate for the surrogate markers. Furthermore, this approach was supported by previously reported results [16, 17] . Histopathologically, lymphatic invasion was determined to be positive when tumour cells floating in lymphatic vessels with no supporting smooth muscles or elastic fibres evaluated by Verhoeff-Van Gieson elastic staining were identified. Lymphatic invasion was evaluated by haematoxylin and eosin (H&E) stain and by the presence of lymphatic endothelial (D2-40) cells if necessary.
Statistical analysis
Continuous variables were compared with the Mann-Whitney U-test. Categorical variables were compared using the v 2 or Fisher's exact test as appropriate. Logistic regression analysis was used to predict lymphatic invasion in uni-and multivariable analyses. A P-value of <0.05 was considered statistically significant, and a probability value <0.05 was set as the cut-off point for the selection of variables for multivariable analysis. Recurrence-free survival was estimated using Kaplan-Meier methods with differences assessed by log-rank tests. All statistical calculations were performed using StatView Version 5.0 statistical software (SAS Institute Inc, Cary, NC).
RESULTS
Relationship between overall patient and pathological invasiveness
In this study, pGGN was observed in 130 patients, GP-PST in 127, CP-PST in 185 and ST in 333. When the patients were divided into four groups, the tumours gradually were more invasive. The frequency of nodal involvement was 0% in pGGN, 0% in GP-PST, 4.3% in CP-PST and 23.7% in ST. The frequency of lymphatic invasion was 0% in pGGN, 0.8% in GP-PST, 16 .8% in CP-PST and 46.2% in ST (Fig. 2) . Early-stage lung cancer was often divided into two groups on the basis of a C/T ratio of 0.5. However, the 5-year survival rate for pure GGNs is nearly 100%, whereas STs may have an occult pN1 or N2, which worsens the prognosis. How they should be classified remains controversial. CTR: consolidation-to-tumour ratio; GGN: ground glass nodule.
Characteristics of the patients with GP-PST and CP-PST Table 1 shows the characteristics of the patients with GP-PST and CP-PST. The mean C/T ratios in the two groups were 0.33 ± 0.097 and 0.70 ± 0.115, respectively (P-value < 0.001). The results indicated that the distribution of the C/T ratio in each group was appropriate. Distributions regarding frequency of tumour size, surgical mode, pleural invasion, nodal involvement, vascular invasion and lymphatic invasion were significant. Tumour size was smaller in GP-PST than in CP-PST patients, and lobectomy was more likely to be performed in patients with CP-PST. Sublobar resections, such as wide wedge resection and segmentectomy, were more likely to be performed in patients with GP-PST. In this study, pneumonectomy was not performed, and no 90-day or in-hospital deaths were observed. The incidence of EGFR mutation was not different between patients with GP-PST and CP-PST (59.4 vs 60.0%).
Predictors for pathological invasiveness of GP-PST and CP-PST
Among PST, the predicators for lymphatic invasion as determined from a univariate analysis were carcinoembryonic antigen, tumour size (T1b) and consolidation-predominant PST (Table 2 ). In the multivariable analysis, predicators for lymphatic invasion were tumour size (T1b) (P-value = 0.003) and consolidationpredominant PST (P-value = 0.005) ( Table 3) .
Recurrence-free survival analysis between GP-PST and CP-PST Median follow-up time was 31 months. The 3-and 5-year recurrence-free survival rates were 98.9 and 98.9% in GP-PST and 96.6 and 91.3% in CP-PST, respectively. The differences in recurrence-free survival rates between GP-PST and CP-PST were statistically significant (P-value = 0.044) (Fig. 3) . Recurrences developed in 11 patients, among whom GP-PST was observed in only one, and CP-PST and T1b were observed in 7 patients.
DISCUSSION
The increased chance of finding small-sized lung cancers on thin-section CT scans has resulted in the need to use many radiological terms, such as GGO, GGN, pure GGN, mixed GGN, PST, nonsolid tumour and ST. However, the definitions of these terms remain unclear [9, 10] . In fact, such cancers are classified into three groups based on thin-section CT scans, namely, pGGN having only a GGO component, PST having both GGO and consolidation components and ST having only a consolidation component. The Japan Clinical Oncology Group 0201 divided early-stage lung cancer into two groups on the basis of a C/T ratio of 0.5 [11, 12] . However, we thought this decision caused a significant problem because the 5-year survival rate of patients with pure GGNs is good, being almost 100%, given that most of these tumours are adenocarcinomas in situ. Conversely, STs that may have an occult pN1 or N2 may have a worse prognosis. Therefore, whether such cancers should be classified into two, three or four groups is controversial. We proposed a simple resolution for this debate, and our study revealed that PST could be divided into ground glass predominant PST and consolidationpredominant PST based on malignant potential and prognosis in early-stage lung cancer. Radiologically, we could classify earlystage lung cancer into four categories: pure GGN, GP-PST, CP-PST and ST.
In this study, the incidence of nodal involvement was 0% in both pGGN and GP-PST, and the incidence of lymphatic invasion was 0% in pGGN and 0.8% in GP-PST (Fig. 2) , showing no statistical significance. However, we considered it better to distinguish the two groups because each group has its own unique problems in practice. The most serious pathological conditions associated with pGGN include atypical adenomatous hyperplasia and adenocarcinoma in situ. The 5-year survival rate for each of these was nearly 100%. Therefore, the problem was how to follow up with pGGNs [15, 18, 19] . Hiramatsu et al. [20] reported that 50 patients without a history of lung cancer had pGGNs that were 10 mm or smaller that did not grow within 3.5 years. Kim et al. [21] reported that the presence of a solid component was the only factor that could predict nodule growth in GGNs. Matsuguma et al. [22] reported that the 2-and 5-year cumulative percentages of a growing nodule were 38 and 55% in PST with a C/T ratio of less than 0.8. So, we thought that surgical intervention was indicated for GP-PST, but determining what surgical procedure to use was a problem. It has been reported that patients with GGO-dominant clinical stage IA adenocarcinomas can be successfully treated with wedge resection of T1a and segmentectomy of T1b [13] . In this study, we performed sublobar resection in about 60% of patients with GP-PSTs; the 5-year recurrence-free survival rate was 98.9% [13] . We performed sublobar resection for GP-PST if the size of the surgical margin was adequate.
The difference between ST and CP-PST was thought to be obvious, although the Japan Clinical Oncology Group 0201 classified ST and CP-PST in the same category [11] . As shown in Fig. 2 , incidences of nodal involvement in this study were 4.3% in CP-PST and 23.7% in ST, and the incidences of lymphatic invasion were 16.8% in CP-PST and 46.2% in ST. The differences were statistically significant (P-value < 0.001 and <0.001, respectively). Furthermore, according to a report by the National Cancer Center in Japan, the incidences of nodal involvement were 5.5% in CP-PST and 24.0% in ST; these findings supported our results [2] . So, we thought that we should distinguish the two groups on the basis of the potential for malignancy. Hattori et al. [6] stated that lymph node metastasis is frequently observed with pure solid lung cancers, especially with tumours that show a high maximum standardized uptake value. Moreover, it has been reported that lobectomy should still be considered the standard operation of choice, even for subcentimeter STs [23] . On the other hand, many positive studies have compared segmentectomy with lobectomy due to the evolution of preoperative radiological evaluation in the modern era. The Lung Cancer Study Group, however, concluded that sublobar resection resulted in a high rate of local recurrence and a low survival rate [24] [25] [26] . Thus, we thought that lobectomy was appropriate for ST and that we should perform lobectomy for patients with CP-PST in general. Segmentectomy, however, could be used as a surgical procedure when an adequate surgical margin is available and there is no nodal involvement intraoperatively, or the patient is high risk because of pulmonary or cardiac dysfunction. Clinical trials comparing surgical results between lobectomy and sublobar resection for clinical T1N0M0 NSCLC are currently being conducted by the Cancer and Leukemia Group B (CALGB 140503) and the Japan Clinical Oncology Group/West Japan Oncology Group (JCOG0802/WJOG4608L); we are awaiting the conclusions on this big debate [27] . The surgical strategy for PST is controversial, and each surgeon determines the surgical procedure to use on the basis of institutional policy and personal experience. One surgeon may perform lobectomy for PST on the basis of evidence from the Lung Cancer Study Group and another may perform segmentectomy or wide wedge resection because of the low malignant potential [13, 25] . Our results provide a simple resolution for this debate: dividing PST into GP-PST and CP-PST. If there was no nodal involvement and the malignant potential was very low, we would recommend sublobar resection for GP-PST if the size of the surgical margin was adequate. If we need to perform lobectomy for GP-PST to preserve the adequate surgical margin, we could omit mediastinal lymph node dissection. We would perform lobectomy and hilar and mediastinal lymph node dissection for CP-PST in general because there could be lymph node metastasis. However, the frequency of lymph node metastasis is only 4.6%, and we could use segmentectomy if there is no nodal involvement intraoperatively in a compromised patient.
Hasegawa et al. [28] reported the CT features of EGFR-mutated adenocarcinoma of the lung. They stated that EGFR-mutated adenocarcinoma showed significantly higher frequencies of multiple bilateral lung metastases, convergence of surrounding structures, surrounding GGO, and notch compared with the non-EGFR-mutated type. The frequency of EGFR-mutated adenocarcinoma with surrounding GGO on CT scans was 54.4%. In this study, the incidence of EGFR mutation among patients with PST was 60%, and it supported our results. EGFR tyrosine kinase inhibitors could be one of the important treatments for relapse in PST with EGFR-mutated adenocarcinoma, although the incidence of relapse was low.
This study was limited in that it was a retrospective study in a single institution and the sample size was small. After considering the potential for malignancy of each tumour on the basis of the radiological findings and tumour location in relation to the limitation of the surgical margins, we decided which surgical procedure to perform, such as wide wedge resection, segmentectomy or lobectomy. We considered our surgical procedures appropriate because none of the patients with PST had a local relapse. Recurrences developed in 11 patients with PST. Bone metastasis was observed in 3 patients, brain metastasis in 1, and liver metastasis in 1 patient. Five patients had contralateral pulmonary metastasis. One patient had a relapse in the mediastinal lymph node and chest wall after undergoing lobectomy. Another important limitation was the fact that the C/T ratio was a subjective marker. Moreover, it was sometimes difficult to measure the maximum diameter of the GGO component [2, 4] . A software package that analyses the C/T ratio automatically is necessary. However, we believe that the C/T ratio was easy to determine in most cases, and it was useful in selecting the appropriate surgical procedure.
In conclusion, a PST comprised two categories in terms of invasiveness and prognosis based on the radiological criterion of a C/T ratio of 0.5. We should therefore distinguish between GP-PST and CP-PST and use these terminologies when determining the respective treatment strategies. The 3-and 5-year recurrence-free survival rates were 98.9 and 98.9% in GP-PST and 96.6 and 91.3% in CP-PST, respectively. The differences were statistically significant (P-value = 0.044). GP-PST: ground glass predominant part-solid tumour; CP-PST: consolidation-predominant part-solid tumour.
